Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer

International Journal of Clinical Oncology

Volumn 13, Issue 6, 2008, Pages 536-540

  Tamura, Shigeyuki ^a   Miki, Hirofumi ^a   Okada, Kaoru ^a   Miyake, Tomohiro ^a   Yoshimura, Mio ^a   Suzuki, Rei ^a   Nakahira, Shin ^a   Nakata, Ken ^a   Okamura, Shu ^a   Sugimoto, Keishi ^a   Takatsuka, Yuichi ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

Advanced gastric cancer; Intraperitoneal chemotherapy; Paclitaxel; Peritoneal dissemination; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; FLUOROURACIL; PACLITAXEL;

ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; COLON STENOSIS; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVISCERATION; FATIGUE; GASTRECTOMY; HISTOLOGY; HUMAN; LAPAROSCOPY; LEUKOPENIA; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PERITONEUM METASTASIS; PILOT STUDY; PRIORITY JOURNAL; SECOND LOOK SURGERY; SIDE EFFECT; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; TOTAL STOMACH RESECTION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG COMBINATIONS; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; NEOPLASM STAGING; OXONIC ACID; PACLITAXEL; PERITONEAL NEOPLASMS; PILOT PROJECTS; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR; TREATMENT OUTCOME;

EID: 57849146583     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0836-5     Document Type: Article

References (25)

1. Y. Yonemura T. Sawa K. Kinoshita 1993 Neoadjuvant chemotherapy for high-grade advanced gastric cancer World J Surg 17 256 262
2. E. Mochiki T. Ohno Y. Kamiyama 2006 Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer Br J Cancer 95 1642 1647
3. K. Yoshida M. Ninomiya N. Takakura 2006 Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer Clin Cancer Res 12 3402 3407
4. P.H. Sugerbaker Y. Yonemura 2000 Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure Oncology 58 96 107
5. S. Fujimoto M. Takahashi K. Kobayashi 1993 Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis Oncology 50 338 343
6. Y. Yonemura T. Kawamura S. Bandou 2005 Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion Br J Surg 92 370 375
7. M. Markman E. Rowinsky T. Harkes 1992 Phase I trial of intraperitoneal Taxol: a Gynecoloic Oncology Group Study J Clin Oncol 10 1485 1491
8. Y. Sakata A. Ohtsu N. Horikoshi 1998 Late phase II study on novel oral fluoropyrimidine anticancer drug S-1 (I M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
9. W. Koizumi M. Kurihara S. Nakano 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197
10. T. Mori Y. Fujiwara M. Yano 2003 Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-fluorouracil Oncology 64 176 182
11. Japanese Gastric Cancer Association 1998 Japanese classification of gastric carcinoma Gastric Cancer 1 25 30
12. Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma. 1st English edn. Kanehara, Tokyo
13. W. Koizumi M. Kurihara S. Tanabe 1999 Advantage of Japanese response criteria for estimating the survival of patients with primary gastric cancer Gastric Cancer 2 14 19
14. Y. Kakeji Y. Maehara M. Tomoda 1998 Long term survival of patients with stage IV gastric cancer Cancer 82 2307 2311
15. A. Kashiwara T. Takahashi O. Kojima 1992 Prophylaxis with carbon-absorbed mitomycin C against peritoneal recurrence of gastric cancer Lancet 339 629 631
16. Y. Yonemura E. Bandou T. Sawa 2006 Neoadjuvant treatment of gastric cancer with peritoneal dissemination Eur J Surg Oncol 32 661 665
17. P. Francis E. Rowinsky J. Schneider 1995 Phase 1 feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot study J Clin Oncol 13 2961 2967
18. M. Markman M.F. Brady N.M. Spirtos 1998 Phase II trial of intraperitoneal Taxol in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study J Clin Oncol 16 1485 1491
19. G. Los P.H.A. Mutsaers W.J.F. van der Vijgh 1989 Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy Cancer Res 49 3380 3384
20. G. Los M.J.H. van Vugt H.M. Pinedo 1994 Response of peritoneal solid tumors after intraperitoneal chemo-hyperthermia treatment with cisplatin and carboplatin Br J Cancer 68 235 241
21. S. Fushida N. Furui S. Kinami 2002 Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination (in Japanese) Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 29 2164 2167
22. Y. Yonemura Y. Endou E. Bando 2004 Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer Cancer Lett 210 189 196
23. S. Tamura H. Miki K. Nakata 2007 Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer Gastric Cancer 10 251 255
24. T. Shirasaka Y. Shimamoto H. Ohshimo 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 557
25. H. Osugi N. Takada M. Takemura 2002 Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination Oncol Rep 9 811 815